Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease

NCT00090558 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: nitroglycerin

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)